Agranulocytosis Following Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma. - Uchida G; Hiraga J; Morita K; Takeuchi A; Takashi H; Furune S; Tsuzuki T (Internal medicine (Tokyo, Japan), 2026)